Concomitant asthma medications in moderate-to-severe allergic asthma treated with omalizumab

Respiratory Medicine

Volumn 107, Issue 1, 2013, Pages 60-67

  Chen, Hubert ^a,b   Eisner, Mark D ^a   Haselkorn, Tmirah ^a   Trzaskoma, Benjamin ^a  

^a GENENTECH INC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Allergic asthma; IgE; Medications; Moderate to severe asthma; Observational study; Omalizumab

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FLUTICASONE; OMALIZUMAB;

ADULT; ALLERGIC ASTHMA; ARTICLE; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENERGIC BETA-AGONISTS; ADULT; ANTI-ASTHMATIC AGENTS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL, HUMANIZED; ASTHMA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; LEUKOTRIENE ANTAGONISTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84871400164     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2012.09.008     Document Type: Article

References (16)

1. Expert Panel Report 3 (EPR-3) Guidelines for the diagnosis and management of asthma-summary report 2007 J Allergy Clin Immunol 120 5 Suppl. 2007 S94 S138
2. L.J. Walsh, C.A. Wong, J. Oborne, S. Cooper, S.A. Lewis, and M. Pringle Adverse effects of oral corticosteroids in relation to dose in patients with lung disease Thorax 56 4 2001 279 284
3. A. Ahmet, H. Kim, and S. Spier Adrenal suppression: a practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy Allergy Asthma Clin Immunol 7 2011 13
4. FDA announces new safety controls for long-acting beta agonists, medications used to treat asthma 18-2-2010 Food and Drug Administration
5. M.S. Broder, E.Y. Chang, T. Kamath, and S. Sapra Poor disease control among insured users of high-dose combination therapy for asthma Allergy Asthma Proc 31 1 2010 60 67
6. N.A. Hanania, O. Alpan, D.L. Hamilos, J.J. Condemi, I. Reyes-Rivera, and J. Zhu Omalizumab in severe allergic asthma inadequately controlled on standard therapy: a randomized trial Ann Intern Med 3-5-2011
7. XOLAIR (omalizumab) [prescribing information] 2010 Genentech, Inc South San Francisco, CA
8. W. Busse, J. Corren, B.Q. Lanier, M. McAlary, A. Fowler-Taylor, and G.D. Cioppa Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma J Allergy Clin Immunol 108 2 2001 184 190
9. M. Soler, J. Matz, R. Townley, R. Buhl, J. O'Brien, and H. Fox The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics Eur Respir J 18 2 2001 254 261
10. S.T. Holgate, A.G. Chuchalin, J. Hebert, J. Lotvall, G.B. Persson, and K.F. Chung Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma Clin Exp Allergy 34 4 2004 632 638
11. W.W. Busse, M. Massanari, F. Kianifard, and G.P. Geba Effect of omalizumab on the need for rescue systemic corticosteroid treatment in patients with moderate-to-severe persistent IgE-mediated allergic asthma: a pooled analysis Curr Med Res Opin 23 10 2007 2379 2386
12. A.A. Long, J.E. Fish, A. Rahmaoui, M.K. Miller, M.S. Bradley, and H.N. Taki Baseline characteristics of patients enrolled in EXCELS: a cohort study Ann Allergy Asthma Immunol 103 3 2009 212 219
13. M.D. Eisner, J.L. Zazzali, M.K. Miller, M.S. Bradley, and M. Schatz Longitudinal changes in asthma control with omalizumab: 2-year interim data from the EXCELS Study Ann Allergy Asthma Immunol 2011
14. M. Schatz, M. Kosinski, A.S. Yarlas, J. Hanlon, M.E. Watson, and P. Jhingran The minimally important difference of the asthma control test J Allergy Clin Immunol 124 4 2009 719 723
15. M. Schatz, M.D. Eisner, J. Zazzali, M.S. Bradley, and M.K. Miller Longitudinal impact of omalizumab on asthma control over two years Am J Resp Crit Care Med 183 2011 A4495
16. M.-H. Lafeuille, M.S. Duh, J. Zhang, D. Wertz, T. Gu, and A. Swensen Concomitant asthma medication use in patients receiving omalizumab: results from three large insurance claims databases J Asthma 2011